Dr. R De Mol: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Dr. R De Mol
Largest movements
- Receivables within one year +€4,202
up €4,202 (+6.2%), from €67,676 to €71,878
- Other debts +€7,978
up €7,978 (+6.3%), from €126,492 to €134,470
- Profit (loss) carried forward -€4,242
down €4,242 (-7.0%), from -€60,732 to -€64,974
- Gross operating margin +€1,672
up €1,672 (+31.3%), from -€5,343 to -€3,671
- Financial charges +€348
up €348 (+9.4%), from €3,683 to €4,030
- Financial income -€229
down €229 (-5.4%), from €4,232 to €4,003
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €71,964 | €75,886 | +€3,922 | +5.4% |
| Current assets | 29/58 | €71,964 | €75,886 | +€3,922 | +5.4% |
| Amounts receivable within one year | 40/41 | €67,676 | €71,878 | +€4,202 | +6.2% |
| Other amounts receivable | 41 | €67,676 | €71,878 | +€4,202 | +6.2% |
| Cash at bank and in hand | 54/58 | €56 | €4 | -€52 | -92.2% |
| Deferred charges and accrued income | 490/1 | €4,232 | €4,003 | -€229 | -5.4% |
| Total equity and liabilities | 10/49 | €71,964 | €75,886 | +€3,922 | +5.4% |
| Equity | 10/15 | -€58,732 | -€62,974 | -€4,242 | -7.2% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€60,732 | -€64,974 | -€4,242 | -7.0% |
| Amounts payable | 17/49 | €130,696 | €138,860 | +€8,164 | +6.2% |
| Amounts payable within one year | 42/48 | €127,014 | €134,911 | +€7,898 | +6.2% |
| Trade debts | 44 | €522 | €442 | -€80 | -15.3% |
| Suppliers | 440/4 | €522 | €442 | -€80 | -15.3% |
| Other amounts payable | 47/48 | €126,492 | €134,470 | +€7,978 | +6.3% |
| Accrued charges and deferred income | 492/3 | €3,683 | €3,949 | +€266 | +7.2% |
| Other operating charges | 640/8 | €519 | €544 | +€25 | +4.8% |
| Gross operating margin | 9900 | -€5,343 | -€3,671 | +€1,672 | +31.3% |
| Operating profit (loss) | 9901 | -€5,862 | -€4,215 | +€1,647 | +28.1% |
| Financial income | 75/76B | €4,232 | €4,003 | -€229 | -5.4% |
| Recurring financial income | 75 | €4,232 | €4,003 | -€229 | -5.4% |
| Financial charges | 65/66B | €3,683 | €4,030 | +€348 | +9.4% |
| Recurring financial charges | 65 | €3,683 | €4,030 | +€348 | +9.4% |
| Profit (loss) for the period before taxes | 9903 | -€5,313 | -€4,242 | +€1,071 | +20.2% |
| Profit (loss) for the period | 9904 | -€5,313 | -€4,242 | +€1,071 | +20.2% |
| Profit (loss) for the period to be appropriated | 9905 | -€5,313 | -€4,242 | +€1,071 | +20.2% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.